Pre-Activity Self-Assessment Question Title 1. Name Question Title 2. Practice Setting Hospital Clinic LTHC Ambulatory Care Community Academia VA Industry Student/Resident Other (please specify) Question Title 3. Which of the following pathogens is not included as an urgent or serious threat by the Centers for Disease Control and Prevention? Carbapenem-resistant Enterobacteriaceae Carbapenem-resistant Acinetobacter Beta-lactamase-producing H. influenzae Multidrug-resistant P. aeruginosa Question Title 4. Risk factors for a multidrug-resistant ventilator-associated bacterial pneumonia (VABP) include all of the following except: Prior intravenous antibiotic use within 90 days Age <60 years 5 or more days of hospitalization Acute renal replacement therapy prior to VABP onset Question Title 5. Which of the following agents would be preferred for the treatment of hospital-acquired bacterial pneumonia (HABP) caused by MDR P. aeruginosa? Ceftolozane-tazobactam Meropenem-vaborbactam Aztreonam plus colistin Eravacycline Question Title 6. Which of the following newer antimicrobials exhibits in vitro activity against metallo-beta-lactamases? Ceftazidime-avibactam Meropenem-vaborbactam Cefiderocol Delafloxacin Thank you for participating and completing the Pre-Activity Self-Assessment form. Done
